Comparison
2p21 Microdeletion Syndrome C4304537 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 2p21 Microdeletion Syndrome and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
2p21 Microdeletion Syndrome C4304537
A rare genetic disorder involving deletion of genetic material on chromosome 2. It may affect multiple body systems and development. Management is tailored to individual symptoms.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
2p21 Microdeletion Syndrome C4304537
0-null
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
2p21 Microdeletion Syndrome C4304537
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome C4304537
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome C4304537
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
2p21 Microdeletion Syndrome C4304537
congenital
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
2p21 Microdeletion Syndrome C4304537
rare-disease
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
2p21-microdeletion-syndrome-C4304537 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p21 Microdeletion Syndrome C4304537 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Loss of genetic material at 2p21 is the defining concept. | Extra material from 15q11-q13, a region linked to Prader-Willi and Angelman syndromes. | High |
| Development | Development and multiple body systems may be affected; exact features are not supplied. | Developmental delay, learning difficulty, and sometimes autism-spectrum traits are described. | Moderate |
| Severity label | Source severity is severe, but this label alone is not diagnostic. | Source severity is moderate and does not establish individual outcome. | Low |
When to favor each condition
Choose 2p21 Microdeletion Syndrome C4304537 when
Testing shows a pathogenic or clinically relevant 2p21 deletion
The locus and copy-number loss match the left condition.
High
Multisystem congenital concerns occur without a 15q duplication
This fits the sparse multisystem description, but genetics must confirm it.
Moderate
Onset information is missing or recorded as null
Supplied left onset is incomplete, so timing should not exclude it.
Low
Choose 15q11q13 Microduplication Syndrome C2675336 when
Testing shows duplication of 15q11-q13
Copy-number gain at this region defines the right condition.
High
Early developmental delay or learning difficulty, sometimes with autism-spectrum traits
These are the features described for the right condition.
Moderate
Concerns are recognized from birth through age 3
The supplied onset axis is 0-3 years, but clinical confirmation is still required.
Moderate
How key tests differ
| Test | 2p21 Microdeletion Syndrome C4304537 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss involving 2p21. | Copy-number gain involving 15q11-q13. | Locus and loss versus gain distinguish them; a laboratory and clinician must judge significance. |
| Karyotype or targeted FISH | A small deletion may not be visible. | A small duplication may not be visible. | A normal result does not exclude either condition. |
| Developmental assessment | Nonspecific developmental or multisystem concerns may be found. | Delay, learning needs, or autism-spectrum traits may be documented. | Assessment guides support but does not replace genetic diagnosis. |
Prognosis comparison
2p21 Microdeletion Syndrome C4304537
- Outcome
- Long-term outcome is not established; the source labels it severe and chronic.
- Factors
- Deletion extent, involved systems, and individual findings; exact predictors are not supplied.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Course varies; the source labels it moderate and chronic, with supportive management.
- Factors
- Developmental profile, learning needs, autism-related traits, and duplication details.
Time frame: Lifelong. Right onset is listed as 0-3 years; left onset data are incomplete.
Genetic result, clinical findings, and access to therapies. Mortality is not established.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Developmental effects are possible; exact pattern is not established. Delay and learning difficulty are described. Needs should be assessed individually rather than inferred from severity labels. |
| Other body systems | Multiple systems may be involved. Multisystem complications are not established from the supplied description. Absence from this summary does not prove absence clinically. |
| Long-term support | Chronic course with potentially substantial support needs. Chronic course often managed with supportive therapies. No treatment dose or standardized protocol is established here. |
Patient education highlights
- HighDiagnosis
The specific chromosomal result, not symptoms alone, distinguishes these conditions.
- HighTransmission
Neither condition is communicable. Inheritance counseling requires the individual genetic report.
- MediumCare
Management is supportive and individualized. No dose or definitive treatment is established here.